4 items

NIH, NIST researchers use artificial intelligence for quality control of stem cell-derived tissues

November 14, 2019

Researchers used artificial intelligence (AI) to evaluate stem cell-derived “patches” of retinal pigment epithelium (RPE) tissue for implanting into the eyes of patients with age-related macular degeneration (AMD), a leading cause of blindness.

NIH researchers rescue photoreceptors, prevent blindness in animal models of retinal degeneration

January 16, 2019

Using a novel patient-specific stem cell-based therapy, researchers at the National Eye Institute (NEI) prevented blindness in animal models of geographic atrophy, the advanced “dry” form of age-related macular degeneration (AMD)...

NIH discovery brings stem cell therapy for eye disease closer to the clinic

January 2, 2018

Scientists at the National Eye Institute (NEI) report that tiny tube-like protrusions called primary cilia on cells of the retinal pigment epithelium (RPE) are essential for the survival of the retina’s light-sensing photoreceptors.

Gene profiling technique to accelerate stem cell therapies for eye diseases

July 16, 2014

Researchers at the National Institutes of Health have developed a technique that will speed up the production of stem-cell derived tissues.